Program Committee
-
Yuji Kumagai, MD, PHD Professor, Kitasato Clinical Research Center
Kitasato University Hospital, Japan -
Keiichi Inaizumi, MSC Clinical Study Innovation Lead, Clinical Project Management Group
Pfizer R&D Japan, Japan -
Taro Amagasaki, PHD Head, Analytics Japan
Novartis Pharma K.K., Japan -
Nobuyuki Hanamura, PHD, MBA Senior Director, Clinical Operations
IQVIA, Japan -
Toshiko Ishibashi, PHD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Kazuhiko Ishida, MSC, RPH Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Yayoi Kitawaki, MS Department Head, Neuroscience, GTx Development Unit
Novartis Pharma K.K., Japan -
Yoshiko Komuro, PHD Director, Office of Research Administration
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takashi Moriya, PHD, MBA Research Fellow
Keio University, KBS (Keio Business School) Graduate School, Japan -
Sumimasa Nagai, MD, PHD Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan -
Shinichi Nishiuma, MD Chief Executive Director
NISHIUMA CO., LTD., Japan -
Mika Ogasawara Data Quality Lead, Biometrics and Data Management
Pfizer R&D Japan G.K., Japan -
Goshi Ozawa, MS CEO
Real Discovery Outdorrs K.K., Japan -
Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
MSD K.K., Japan -
Junichi Nishino, MSC, RPH Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Hironobu Saito, PHD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PHD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takashi Sato, MSC, PMP
PM Orchestra Takashi Sato, Japan -
Atsushi Tsukamoto, PHD, MSC Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
Have an account?